Svb Wealth LLC Abbott Laboratories Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $1.53 Million - $1.71 Million	-15,221 Reduced 5.05%	286,061 $29.7 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $859,293 - $949,052	-7,846 Reduced 2.54%	301,282 $34.2 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $4.61 Million - $5.64 Million	-51,128 Reduced 14.19%	309,128 $34 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $1.99 Million - $2.39 Million	-20,870 Reduced 5.48%	360,256 $34.9 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $9.3 Million - $10.4 Million	-92,232 Reduced 19.48%	381,126 $41.6 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $4.08 Million - $4.8 Million	-42,135 Reduced 8.17%	473,358 $47.9 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $638,993 - $749,637	-6,722 Reduced 1.29%	515,493 $56.6 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $442,580 - $512,425	4,574 Added 0.88%	522,215 $50.5 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $406,238 - $491,012	3,980 Added 0.77%	517,641 $56.2 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $2.12 Million - $2.59 Million	18,635 Added 3.76%	513,661 $60.8 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $342,430 - $419,287	2,964 Added 0.6%	495,026 $69.7 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $1.67 Million - $1.84 Million	-14,274 Reduced 2.82%	492,062 $58.1 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $898,580 - $1.06 Million	-8,494 Reduced 1.65%	506,336 $58.7 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $5.38 Million - $6.34 Million	-49,413 Reduced 8.76%	514,830 $61.7 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $2.71 Million - $2.95 Million	-25,787 Reduced 4.37%	564,243 $61.8 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $23,276 - $28,267	254 Added 0.04%	590,030 $64.2 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $1.04 Million - $1.33 Million	13,605 Added 2.36%	589,776 $53.9 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $936,332 - $1.37 Million	14,905 Added 2.66%	576,171 $45.5 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $355,571 - $395,834	-4,529 Reduced 0.8%	561,266 $48.8 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $239,545 - $259,741	-2,927 Reduced 0.51%	565,795 $47.3 Million
Q2 2019 Jul 10, 2019	SELL	$72.88 - $85.0 $797,963 - $930,665	-10,949 Reduced 1.89%	568,722 $47.8 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $1.83 Million - $2.21 Million	27,576 Added 4.99%	579,671 $46.3 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.06 Million - $1.2 Million	16,182 Added 3.02%	552,095 $39.9 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $29,188 - $35,212	480 Added 0.09%	535,913 $39.3 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $49,510 - $54,644	-860 Reduced 0.16%	535,433 $32.7 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $150,184 - $169,801	-2,669 Reduced 0.5%	536,293 $32.1 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $138,064 - $147,812	-2,572 Reduced 0.47%	538,962 $30.8 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $26 Million - $29 Million	541,534	541,534 $28.9 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account